Effect of Adalimumab on Clinical Outcomes and Health-related Quality of Life Among Patients With Ulcerative Colitis in a Clinical Practice Setting: Results From InspirADA

BACKGROUND AND AIMS: Randomised trials have described the benefits of adalimumab [ADA] for ulcerative colitis [UC]; however, few data are available on health-related quality of life [HRQL] and health care costs in clinical practice. METHODS: InspirADA, a multicentre, prospective study, evaluated the...

Descripción completa

Detalles Bibliográficos
Autores principales: Travis, Simon, Feagan, Brian G, Peyrin-Biroulet, Laurent, Panaccione, Remo, Danese, Silvio, Lazar, Andreas, Robinson, Anne M, Petersson, Joel, Pappalardo, Brandee L, Bereswill, Mareike, Chen, Naijun, Wang, Song, Skup, Martha, Thakkar, Roopal B, Chao, Jingdong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5881702/
https://www.ncbi.nlm.nih.gov/pubmed/28981846
http://dx.doi.org/10.1093/ecco-jcc/jjx093

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5881702/
https://www.ncbi.nlm.nih.gov/pubmed/28981846
http://dx.doi.org/10.1093/ecco-jcc/jjx093

Ejemplares similares